Skip to search formSkip to main content
You are currently offline. Some features of the site may not work correctly.

LY2784544

Known as: LY 2784544 
 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2018
2018
BACKGROUND The Philadelphia chromosome-negative myeloproliferative neoplasms (MPNs) are associated with increases in janus kinase… Expand
Is this relevant?
2017
2017
Mutations in Janus kinase 2 (JAK2) are implicated in the pathogenesis of Philadelphia-chromosome negative myeloproliferative… Expand
  • figure 1
  • figure 2
  • table 1
  • table 2
  • table 3
Is this relevant?
2016
2016
In this study, we identified two previously described kinase inhibitors-3-(4-chloro-2-fluorobenzyl)-2-methyl-N-(3-methyl-1H… Expand
  • table 1
  • table 2
  • table 4
  • table 6
  • table 7
Is this relevant?
2015
2015
The CDH1 gene, which encodes the cell-to-cell adhesion protein E-cadherin, is frequently mutated in lobular breast cancer (LBC… Expand
  • figure 2
  • figure 3
  • table 1
  • figure 4
Is this relevant?
2014
2014
We report a detailed investigation into the application of visible light-mediated photocatalysis to a challenging bond… Expand
  • table 1
  • figure 1
  • table 2
  • table 3
  • figure 2
Is this relevant?
2013
2013
Owing to the prevalence of the JAK2V617F mutation in myeloproliferative neoplasms (MPNs), its constitutive activity, and ability… Expand
  • figure 1
  • table 1
  • figure 2
  • table 2
  • figure 3
Is this relevant?
2013
2013
The Janus family kinases (JAKs), JAK1, JAK2, JAK3, and TYK2, are involved in cell growth, survival, development, and… Expand
Is this relevant?
2011
2011
Abstract 2814 Background: The majority of primary and secondary MF, PV, and ET neoplasms are characterized by gain-of-function… Expand
Is this relevant?
2010
2010
Abstract 4087 Introduction: The JAK2-V617F mutation is the most common molecular abnormality in the BCR/ABL-negative myeloid… Expand
Is this relevant?
2010
2010
Abstract 5054 Introduction: The discovery of JAK2 V617F mutation in patients with myeloproliferative disorders (MPD) has opened… Expand
Is this relevant?